Premium Nahrungsergänzungsmittel | artgerecht

Ketosis-Prone Diabetes – Causes, Symptoms & Treatment

Ketosis-prone diabetes is a unique form of diabetes characterized by episodes of diabetic ketoacidosis, followed by remission phases without insulin therapy.

Regular tips about health Regular tips about health

Things worth knowing about "Ketosis-Prone Diabetes"

Ketosis-prone diabetes is a unique form of diabetes characterized by episodes of diabetic ketoacidosis, followed by remission phases without insulin therapy.

What is Ketosis-Prone Diabetes?

Ketosis-prone diabetes (KPD) is a distinct subtype of diabetes mellitus that does not fit neatly into either the classic type 1 or type 2 categories. Patients typically present with diabetic ketoacidosis (DKA) – a potentially life-threatening condition marked by high levels of ketone bodies in the blood – as their initial manifestation. Remarkably, after acute treatment, many patients can achieve remission and manage without insulin therapy for months or even years. This condition is also known as atypical diabetes, Flatbush diabetes, or type 1.5 diabetes, and it occurs most frequently in individuals of African, Hispanic, or South Asian descent.

Causes

The exact causes of ketosis-prone diabetes are not yet fully understood. Several contributing factors have been identified:

Transient beta-cell dysfunction: The insulin-producing cells of the pancreas fail temporarily but recover after the metabolic stress is relieved.
Genetic predisposition: Certain genetic variants, especially in individuals of African descent, increase susceptibility.
Insulin resistance: Similar to type 2 diabetes, obesity and metabolic syndrome play a significant role.
Absence of autoimmunity: Unlike type 1 diabetes, autoantibodies against pancreatic islet cells are typically absent.
Glucotoxicity: Chronically elevated blood glucose levels damage the beta cells, potentially triggering acute ketoacidosis.

Symptoms

Symptoms of ketosis-prone diabetes resemble those of a classic diabetic ketoacidosis episode and may include:

Excessive thirst and frequent urination
Unintentional weight loss
Nausea, vomiting, and abdominal pain
Fruity or acetone-like breath odor
Deep, rapid breathing (Kussmaul respiration)
Fatigue and weakness
Confusion or loss of consciousness in severe cases

Following successful treatment, patients commonly enter a remission phase during which little or no insulin is required to maintain normal blood glucose levels.

Diagnosis

Diagnosing ketosis-prone diabetes requires careful differentiation from type 1 and type 2 diabetes. Common diagnostic steps include:

Blood glucose measurement: Confirming significantly elevated blood sugar levels.
Blood gas analysis: Detecting metabolic acidosis (lowered blood pH).
Ketone body testing: Elevated ketones in blood and urine confirm ketoacidosis.
C-peptide levels: Assessing residual insulin secretion capacity of the pancreas.
Autoantibody testing: In KPD, autoantibodies typical of type 1 diabetes (such as GAD65, IA-2, ZnT8) are usually absent.
HbA1c: Evaluating long-term glycemic control.

Treatment

Acute Management of Ketoacidosis

During the acute phase, immediate medical intervention is required:

Intravenous fluid resuscitation to correct dehydration
Insulin therapy to lower blood glucose and suppress ketone body production
Electrolyte replacement, particularly potassium

Long-Term Management and Remission

After stabilization, many patients with ketosis-prone diabetes can taper off insulin and transition to oral antidiabetic medications. Long-term management strategies typically include:

Regular blood glucose monitoring
Dietary adjustments (low-carbohydrate, balanced nutrition)
Weight reduction in overweight individuals
Regular physical activity
Metformin or other oral antidiabetics during remission

It is important to note that patients with KPD remain at elevated risk of recurrent DKA episodes, especially during illness, physiological stress, or non-adherence to treatment.

References

Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Annals of Internal Medicine. 2006;144(5):350-357.
Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645-653.
World Health Organization (WHO). Classification of Diabetes Mellitus. Geneva: WHO; 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.